Competitive Technologies to Participate at AUTM Conference.FAIRFIELD, Conn. -- Competitive Technologies, Inc. (AMEX AMEX See: American Stock Exchange : CTT CTT Correios (Portuguese Postal Service) CTT Certified Technical Trainer CTT Charity Technology Trust CTT Cholesterol Treatment Trialists' (collaboration) CTT Common Task Training ) today announced that once again it will showcase its clients' technologies at the Association of University Technology Managers The Association of University Technology Managers (AUTM) is an organization devoted to promoting technology transfer between universities and colleges and private enterprise and/or the government. (AUTM AUTM Association of University Technology Managers AUTM Authorised Unusable Time (Loran-C System) ) Annual Meeting in Orlando, FL, to be held from March 2 through March 4, 2006. This premiere educational conference draws an audience of more than 1500 technology transfer and intellectual property professionals from around the world. Competitive Technologies' business development and technology team will be displaying and discussing a broad variety of patented technologies available for license. These include Event Driven Information System intellectual property, including those using Radio Frequency Identification See RFID. (RFID (Radio Frequency IDentification) A data collection technology that uses electronic tags for storing data. The tag, also known as an "electronic label," "transponder" or "code plate," is made up of an RFID chip attached to an antenna. ), CTT's Homocysteine Homocysteine Definition Homocysteine is a naturally occurring amino acid found in blood plasma. High levels of homocysteine in the blood are believed to increase the chance of heart disease, stroke, Alzheimer's disease, and osteoporosis. Assay, a Cholesterol Removal Technology for producing low cholesterol dairy products while retaining the taste and texture of the food product, cardiovascular diagnostic assay products, the American Type Culture Collection American Type Culture Collection (ATCC) is a private, not-for-profit biological resource center whose mission focuses on the acquisition, authentication, production, preservation, development and distribution of standard reference microorganisms, cell lines and other materials for (ATCC ATCC American Type Culture Collection, see there (R)) Escrow Service, and others. Dr. Mike Kiley, CTT's Executive Vice President and Chief Technology Officer stated "Without exaggeration, the AUTM meeting is one of the world's premiere technology transfer events. We will be working both sides of the equation, simultaneously seeking new technologies to add to our portfolio and offering licensing opportunities for technologies we currently represent." Learn more about the AUTM meeting at www.autm.net and visit Competitive Technologies at AUTM. We will be located right near one of the entrances at booth numbers E5 and E6. About Competitive Technologies, Inc. Competitive Technologies, established in 1968, is a full service technology transfer and licensing provider focused on the technology needs of its customers and transforming those requirements into commercially viable solutions. CTT is a global leader in identifying, developing and commercializing innovative technologies in life and physical sciences, electronics, and nanotechnologies developed by universities, companies and inventors. CTT maximizes the value of intellectual assets for the benefit of its customers, clients and shareholders. Visit our website at: www.competitivetech.net. Statements about our future expectations, including development and regulatory plans, and all other statements in this press release, other than historical facts, are "forward-looking statements" within the meaning of applicable Federal Securities Laws, and are not guarantees of future performance. If and when used herein, the words "may," "will," "should," "anticipate," "believe," "intend," "plan," "expect," "estimate," "approximate," and similar expressions, as they relate to us or our business or management, are intended to identify such forward-looking statements. These statements involve risks and uncertainties related to market acceptance of and competition for our licensed technologies, growth strategies, operating performance, industry trends, and other risks and uncertainties inherent in our business, including those set forth in Item 7 under the caption "Risk Factors," in our most recent Annual Report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. for the year ended July 31, 2005, filed with the Securities and Exchange Commission ("SEC") on October 13, 2005, and other factors that may be described in our other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward-looking statement. |
|
||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion